I lead the clinical development of HIV broadly neutralizing monoclonal antibodies (bnAbs) for HIV prevention at the HVTN (HIV Vaccine Trials Network) headquarters at the Fred Hutch Cancer Center in Seattle, WA, USA.
Appearances:
Festival of Biologics Day 2 @ 13:20
Next generation mAbs: new frontiers in cancer treatment
Huub Gelderblom / Next generation mAbs: new frontiers in cancer treatment
Huub Gelderblom, Director, Fred Hutch
I lead the clinical development of HIV broadly neutralizing monoclonal antibodies (bnAbs) for HIV prevention at the HVTN (HIV Vaccine Trials Network) headquarters at the Fred Hutch Cancer Center in Seattle, WA, USA.